184 related articles for article (PubMed ID: 31859243)
1. Prior authorization as a utilization management tool for elective superficial venous procedures results in high administrative cost and low efficacy in reducing utilization.
Lee V; Berland T; Jacobowitz G; Rockman C; Sadek M; Barfield M; Cayne N; Maldonado TS
J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):383-389.e1. PubMed ID: 31859243
[TBL] [Abstract][Full Text] [Related]
2. Prior authorization requirements in the office-based laboratory setting are administratively inefficient and threaten timeliness of care.
Harish KB; Chervonski E; Speranza G; Maldonado TS; Garg K; Sadek M; Rockman CB; Jacobowitz GR; Berland TL
J Vasc Surg; 2024 May; 79(5):1195-1203. PubMed ID: 38135169
[TBL] [Abstract][Full Text] [Related]
3. Administrative Burden and Costs of Prior Authorizations in a Dermatology Department.
Carlisle RP; Flint ND; Hopkins ZH; Eliason MJ; Duffin KC; Secrest AM
JAMA Dermatol; 2020 Oct; 156(10):1074-1078. PubMed ID: 32845288
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice.
Merrill JR; Flitcroft MA; Miller T; Beichner B; Clarke CN; Maduekwe UN; Wang TS; Dream S; Christians KK; Gamblin TC; Evans DB; Kothari AN
J Surg Res; 2023 Aug; 288():269-274. PubMed ID: 37037166
[TBL] [Abstract][Full Text] [Related]
5. Significant physician practice variability in the utilization of endovenous thermal ablation in the 2017 Medicare population.
Mann M; Wang P; Schul M; Khilnani NM; Park A; Makary MA; Hicks CW
J Vasc Surg Venous Lymphat Disord; 2019 Nov; 7(6):808-816.e1. PubMed ID: 31495766
[TBL] [Abstract][Full Text] [Related]
6. Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers.
Doshi JA; Puckett JT; Parmacek MS; Rader DJ
Circ Cardiovasc Qual Outcomes; 2018 Jan; 11(1):e003939. PubMed ID: 29326146
[TBL] [Abstract][Full Text] [Related]
7. A real world analysis of payment per unit time in a Maryland Vascular Practice.
Martin JD; Warble PB; Hupp JA; Mapes JE; Stanziale SF; Weiss LL; Schiller TB; Hanson LA
J Vasc Surg; 2010 Oct; 52(4):1094-8; discussion 1098-9. PubMed ID: 20619578
[TBL] [Abstract][Full Text] [Related]
8. Strategic Operational Redesign for Successfully Navigating Prior Authorization Barriers at a Large-Volume Proton Therapy Center.
Brooks ED; Ning MS; Palmer MB; Gunn GB; Frank SJ; Shah AK
JCO Oncol Pract; 2020 Oct; 16(10):e1067-e1077. PubMed ID: 32639929
[TBL] [Abstract][Full Text] [Related]
9. Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative's Prior Authorization Learning Collaborative.
Psotka MA; Singletary EA; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; McClellan MB; Brown N;
Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006564. PubMed ID: 32683983
[TBL] [Abstract][Full Text] [Related]
10. The impact of prior authorization review on orthopaedic subspecialty care: a prospective multicenter analysis.
Jarrett CD; Dawes A; Abdelshahed M; Cil A; Denard P; Port J; Weinstein D; Wright MA; Bushnell BD
J Shoulder Elbow Surg; 2024 Jun; 33(6):e336-e342. PubMed ID: 37993089
[TBL] [Abstract][Full Text] [Related]
11. Burden of Prior Authorization Requirements on Urology Practice and Patients.
Sundaram P; Bhatt V; Feustel P; Mian B
Urology; 2022 Nov; 169():76-83. PubMed ID: 35961563
[TBL] [Abstract][Full Text] [Related]
12. Impact of Medicare denials on noninvasive vascular diagnostic testing.
Passman MA; Guzman RJ; Pierce R; Naslund TC
J Vasc Surg; 2001 Nov; 34(5):846-53. PubMed ID: 11700485
[TBL] [Abstract][Full Text] [Related]
13. A proactive medical necessity review program reduces revenue loss associated with outpatient medical benefit drugs.
Hawes EM; Misita CP; Amerine LB; Francart SJ
Am J Health Syst Pharm; 2021 Aug; 78(17):1591-1599. PubMed ID: 33599737
[TBL] [Abstract][Full Text] [Related]
14. Prior Authorization Leads to Administrative Burden and Delays in Treatment in Primary Total Joint Arthroplasty Patients.
Lizcano JD; Goh GS; Tarabichi S; Krueger CA; Austin MS; Courtney PM
J Arthroplasty; 2024 Mar; ():. PubMed ID: 38493967
[TBL] [Abstract][Full Text] [Related]
15. Future of vascular surgery is in the office.
Jain KM; Munn J; Rummel M; Vaddineni S; Longton C
J Vasc Surg; 2010 Feb; 51(2):509-13; discussion 513-4. PubMed ID: 20141969
[TBL] [Abstract][Full Text] [Related]
16. Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System.
Tseng P; Kaplan RS; Richman BD; Shah MA; Schulman KA
JAMA; 2018 Feb; 319(7):691-697. PubMed ID: 29466590
[TBL] [Abstract][Full Text] [Related]
17. Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review.
Popatia S; Flood KS; Golbari NM; Patel PV; Olbricht SM; Kimball AB; Porter ML
J Am Acad Dermatol; 2019 Dec; 81(6):1308-1318. PubMed ID: 31103568
[TBL] [Abstract][Full Text] [Related]
18. Impact of Prior Authorization on Patient Access to Cancer Care.
Trapani D; Kraemer L; Rugo HS; Lin NU
Am Soc Clin Oncol Educ Book; 2023 May; 43():e100036. PubMed ID: 37220314
[TBL] [Abstract][Full Text] [Related]
19. A review of United States endovenous ablation practice trends from the Medicare Data Utilization and Payment Database.
Crawford JM; Gasparis A; Almeida J; Elias S; Wakefield T; Lal BK; Osborne N; Amery S; Labropoulos N
J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):471-479. PubMed ID: 31203856
[TBL] [Abstract][Full Text] [Related]
20. Inhouse authorization center to improve reimbursement for outpatient chemotherapy infusions.
Desai SS
Am J Health Syst Pharm; 2011 May; 68(9):828-34. PubMed ID: 21515867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
